Use of Platelet-enriched Plasma During Auricular Reconstruction

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

In this study investigators are trying to determine the benefits of using platelet enriched plasma during the second stage of auricular reconstruction. The intervention will be blinded to the surgeon and the surgical team. The main outcome will be the evaluation of the integration rate of the skin full thickness graft used to coat the auricular frame.

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06147531` - Delayed Cold-Stored Platelets -PLTS-1	Phase 2
Completed	`NCT05506748` - Association Between Preoperative HALP and Immediate Postoperative Outcomes
Recruiting	`NCT06033300` - Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced Thrombocytopenia	N/A

NCT number	NCT03215979
Study type	Interventional
Source	Hospital General Dr. Manuel Gea González
Contact
Status	Recruiting
Phase	N/A
Start date	June 29, 2017
Completion date	December 10, 2018

Use of Platelet-enriched Plasma During Auricular Reconstruction

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms